Rifaximin on Visceral Hypersensitivity
Clinical trial NCT03462966 · TERMINATED
Trial details
- NCT number
- NCT03462966
- Sponsor
- Cedars-Sinai Medical Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-01
- Primary completion
- 2021-11-19
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.